Literature DB >> 15388075

Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment.

Muna Ahmed1, Ghassan Zein, Faizullah Khawaja, C Stephen Foster.   

Abstract

Understanding of ocular cicatricial pemphigoid (OCP) has changed dramatically over the last three decades. Progress in basic science research in mucous membrane pemphigoid has been instrumental in outlining the key immune processes that participate in the autoimmune response. Immunomodulatory therapy has provided an avenue for preserving vision and preventing potentially fatal consequences of systemic pemphigoid. In this chapter we focus attention on the immunologic basis for disease and treatment strategies. We propose an algorithmic approach to diagnosis and management of OCP.

Mesh:

Year:  2004        PMID: 15388075     DOI: 10.1016/j.preteyeres.2004.05.005

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  19 in total

Review 1.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Clinical features and in vivo confocal microscopy assessment in 12 patients with ocular cicatricial pemphigoid.

Authors:  Qin Long; Ya-Gang Zuo; Xue Yang; Ting-Ting Gao; Jie Liu; Ying Li
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

3.  Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid.

Authors:  Valerie P J Saw; Enno Schmidt; Ifeoma Offiah; Grazyna Galatowicz; Detlef Zillikens; John K G Dart; Virginia L Calder; Julie T Daniels
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 4.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

5.  Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.

Authors:  Samer N Arafat; Ana M Suelves; Sandra Spurr-Michaud; James Chodosh; C Stephen Foster; Claes H Dohlman; Ilene K Gipson
Journal:  Ophthalmology       Date:  2013-08-17       Impact factor: 12.079

6.  Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom.

Authors:  G P Williams; C Radford; P Nightingale; J K G Dart; S Rauz
Journal:  Eye (Lond)       Date:  2011-07-29       Impact factor: 3.775

7.  T-helper 17 lymphocytes in ocular cicatricial pemphigoid.

Authors:  Alessandro Lambiase; Alessandra Micera; Flavio Mantelli; Caterina Moretti; Antonio Di Zazzo; Eleonora Perrella; Sergio Bonini; Stefano Bonini
Journal:  Mol Vis       Date:  2009-07-28       Impact factor: 2.367

8.  Improvement in ocular cicatricial pemphigoid following treatment for porphyria cutanea tarda.

Authors:  R Marshall Ford; Yousuf M Khalifa
Journal:  Clin Ophthalmol       Date:  2012-10-24

9.  Ocular cicatricial pemphigoid masquerading as chronic conjunctivitis: a case report.

Authors:  Joanna Dacosta
Journal:  Clin Ophthalmol       Date:  2012-12-14

10.  Morselized Amniotic Membrane Tissue for Refractory Corneal Epithelial Defects in Cicatricial Ocular Surface Diseases.

Authors:  Anny M S Cheng; Lorraine Chua; Victoria Casas; Scheffer C G Tseng
Journal:  Transl Vis Sci Technol       Date:  2016-05-18       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.